The genomic rearrangements leading to the fusion of the AR-regulated TMPRSS2 gene promoter and the N-terminally deleted ERG coding sequence represents the most common prostate cancer-specific driver gene alteration [60,76,77]. This evidence concerns the gene TMPRSS2 and Familial prostate cancer.